Secondary Markets to Drive Equine Healthcare Market to USD 411 Million by 2020

According to a market research report published by iHealthcareAnalyst, Inc., Equine Healthcare Market – Global Diagnostics and Therapeutics Products Analysis and Forecast 2013-2020, the global equine health care market was valued at USD 309 Million in 2014 and is estimated to reach USD 411 Million by 2020, at a CAGR of 4.9% from 2015 to 2020.

Browse the Equine Healthcare Market – Global Diagnostics and Therapeutics Products Analysis and Forecast 2013-2020 at http://www.ihealthcareanalyst.com/report/equine-healthcare-market/

The structure of the equine industry is diverse and offers a wide variety of business opportunities. Growing interest in natural horsemanship techniques and products, as well as continued R&D efforts to develop new feed, diagnostics, therapeutics and supplements targeting equine-specific health issues, are additional positive signs that the equine health care market is likely to flourish in the near future. The U.S. and the Middle East, particularly the racing nations of the U.A.E. and other Gulf States are proving to be successful targets for exporters of racing, endurance and healthcare related products such as feed, supplements, diagnostics and therapeutics. The equine health care market report estimates the market size (Revenue USD million - 2013 to 2020) and composition of this market and forecasts growth trends (CAGR% - 2015 to 2020). It also tracks the major competitors participating in the equine market and provides a bird’s eye view of the major equine products in the global market.

The global equine health care market is segmented as:

5. Diagnostic Products
5.1. Genotyping Analysis
5.1.1. Quality Analyzers/Genotype Analyzers Kits
5.1.2. Genetic Disease Identification Products (Semen Quality Analyzers)
5.2. Pregnancy and Gestation
5.2.1. UltraSound Devices
5.2.2. Urine Test Kits

6. Therapeutic Products
6.1. Antibacterials
6.2. Anti-inflammatory Drugs
6.3. Antiprotozoals
6.4. Antivirals
6.5. Dopamine Agonists
6.6. Laxatives
6.7. Vaccines

7. Supplement Products
7.1. Performance Supplements
7.1.1. Electrolyte Supplements
7.1.2. Proteins and Amino Acids Supplements
7.1.3. Vitamin Supplements
7.1.4. Others
7.2. Protection Products
7.2.1. Prosthetic products

8. Geography (Region, Country)
8.1. North America (U.S., Canada)
8.2. Latin America (Brazil, Mexico, Rest of LA)
8.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
8.4. Asia Pacific (Japan, China, India, Rest of APAC)
8.5. Rest of the World

9. Company Profiles
9.1. Affymetrix, Inc.
9.2. Bayer
9.3. Boerhringer Ingelheim Vetmedica, Inc. (BIVI)
9.4. Elanco Animal Health
9.5. Equine Diagnostics
9.6. Equine Orthotics and Prosthetics
9.7. Equine Products (UK) Ltd.
9.8. Merck Animal Health
9.9. Purina Mills, LLC
9.10. Signostics Limited
9.11. Zoetis, Inc.

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company has published more than 150+ syndicate, custom and consulting grade healthcare reports covering 70+ companies and 20+ countries in animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Phone: (314) 736-9294.
Email: sales@ihealthcareanalyst.com
http://www.ihealthcareanalyst.com

This release was published on openPR.